Trial Profile
Randomized, double-blind, double-dummy trial of two sustained release formulations of carisoprodol compared to placebo in subjects with acute, painful, musculoskeletal spasm of the lower back
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Nov 2011
Price :
$35
*
At a glance
- Drugs Carisoprodol (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 04 Feb 2010 Primary endpoint 'Patient assessment of pain' has been met according to a Meda media release.
- 04 Feb 2010 Primary endpoint 'Patient assessment of pain' has been met according to a Meda media release.
- 06 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov